$HR
Healthcare Realty Trust Inc Stock $hr

$hr Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000136060422000031 Filed on May 09, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$202.0M	$191.5M
YoY Change	5.49%	3.08%
Cost Of Revenue	$57.46M	$52.20M
YoY Change	10.08%	5.24%
Gross Profit	$85.43M	$78.10M
YoY Change	9.39%	3.72%
Gross Profit Margin	42.29%	40.78%
Selling, General & Admin	$11.04M	$8.500M
YoY Change	29.84%	-3.41%
% of Gross Profit	12.92%	10.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$71.01M	$50.10M
YoY Change	41.73%	5.47%
% of Gross Profit	83.12%	64.15%
Operating Expenses	$65.08M	$58.60M
YoY Change	11.05%	4.27%
Operating Profit	$20.35M	$19.50M
YoY Change	4.37%	2.09%
Interest Expense	$23.94M	$22.99M
YoY Change	4.15%	-3.71%
% of Operating Profit	117.62%	117.88%
Other Income/Expense, Net	$88.00K	$3.000K
YoY Change	2833.33%	-96.05%
Pretax Income	$42.23M	$24.00M
YoY Change	75.95%	458.14%
Income Tax
% Of Pretax Income
Net Earnings	$18.32M	$22.03M
YoY Change	-16.86%	23.07%
Net Earnings / Revenue	9.07%	11.5%
Basic Earnings Per Share	$0.08	$0.10
Diluted Earnings Per Share	$0.08	$0.10
COMMON SHARES
Basic Shares Outstanding	229.0M shares	218.8M shares
Diluted Shares Outstanding	233.0M shares	222.3M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.94M	$12.10M
YoY Change	-9.55%	-88.3%
Cash & Equivalents	$10.94M	$29.99M
Short-Term Investments
Other Short-Term Assets	$42.73M	$47.00M
YoY Change	-9.08%	-9.62%
Inventory
Prepaid Expenses
Receivables	$3.009M	$12.00M
Other Receivables	$153.8M	$136.0M
Total Short-Term Assets	$210.5M	$12.10M
YoY Change	1639.4%	-88.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.392B	$3.512B
YoY Change	82.04%	1.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$62.50M	$64.00M
YoY Change	-2.34%	-2.29%
Other Assets	$63.15M	$64.60M
YoY Change	-2.25%
Total Long-Term Assets	$6.604B	$6.684B
YoY Change	-1.2%	-0.54%
TOTAL ASSETS
Total Short-Term Assets	$210.5M	$12.10M
Total Long-Term Assets	$6.604B	$6.684B
Total Assets	$6.815B	$6.697B
YoY Change	1.77%	-1.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$159.7M	$66.40M
YoY Change	140.45%	2.79%
Accrued Expenses	$196.2M	$91.90M
YoY Change	113.52%	0.88%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00
YoY Change		-100.0%
Total Short-Term Liabilities	$434.7M	$158.3M
YoY Change	174.58%	1.67%
LONG-TERM LIABILITIES
Long-Term Debt	$3.054B	$1.628B
YoY Change	87.59%	-2.07%
Other Long-Term Liabilities	$30.00M	$69.70M
YoY Change	-56.96%	-0.57%
Total Long-Term Liabilities	$3.084B	$1.698B
YoY Change	81.65%	-2.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$434.7M	$158.3M
Total Long-Term Liabilities	$3.084B	$1.698B
Total Liabilities	$3.519B	$3.508B
YoY Change	0.31%	2.58%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$5.183B	$4.919B
YoY Change	5.36%	0.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.213B	$1.998B
YoY Change
Total Liabilities & Shareholders Equity	$6.815B	$6.697B
YoY Change	1.77%	-1.87%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$18.32M	$22.03M
YoY Change	-16.86%	23.07%
Depreciation, Depletion And Amortization	$71.01M	$50.10M
YoY Change	41.73%	5.47%
Cash From Operating Activities	$49.31M	$65.35M
YoY Change	-24.55%	-13.35%
INVESTING ACTIVITIES
Capital Expenditures	-$58.03M	-$84.20M
YoY Change	-31.09%	-20.34%
Acquisitions
YoY Change
Other Investing Activities	$24.85M	$14.40M
YoY Change	72.54%	-676.0%
Cash From Investing Activities	-$33.18M	-$76.30M
YoY Change	-56.51%	-0.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.641M	$3.248M
YoY Change	-49.48%	-107.15%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$57.78M	-$74.73M
YoY Change	-22.69%	-140.38%
NET CHANGE
Cash From Operating Activities	$49.31M	$65.35M
Cash From Investing Activities	-$33.18M	-$76.30M
Cash From Financing Activities	-$57.78M	-$74.73M
Net Change In Cash	-$41.65M	-$85.68M
YoY Change	-51.39%	-146.6%
FREE CASH FLOW
Cash From Operating Activities	$49.31M	$65.35M
Capital Expenditures	-$58.03M	-$84.20M
Free Cash Flow	$107.3M	$149.6M
YoY Change	-28.23%	-17.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity File Number EntityFileNumber	001-35568
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	HEALTHCARE TRUST OF AMERICA, INC.
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001360604
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-4738467
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	16435 N. Scottsdale Road, Suite 320,
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Scottsdale,
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85254
CY2022Q1	dei	City Area Code CityAreaCode	(480)
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	998-3478
CY2022Q1	dei	Security12b Title Security12bTitle	Common stock, $0.01 par value
CY2022Q1	dei	Trading Symbol TradingSymbol	HTA
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	229075890	shares
CY2022Q1	us-gaap	Land Land	644194000	USD
CY2021Q4	us-gaap	Land Land	640382000	USD
CY2022Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	6744865000	USD
CY2021Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	6688516000	USD
CY2022Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	393756000	USD
CY2021Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	404714000	USD
CY2022Q1	us-gaap	Development In Process DevelopmentInProcess	15673000	USD
CY2021Q4	us-gaap	Development In Process DevelopmentInProcess	32685000	USD
CY2022Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	7798488000	USD
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	7766297000	USD
CY2022Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1650257000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1598468000	USD
CY2022Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	6148231000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	6167829000	USD
CY2022Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	USD
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	27070000	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	62454000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	62834000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10944000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52353000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4478000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4716000	USD
CY2022Q1	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	350781000	USD
CY2021Q4	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	334941000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	228009000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	229226000	USD
CY2022Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	10011000	USD
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	10720000	USD
CY2022Q1	us-gaap	Assets Assets	6814908000	USD
CY2021Q4	us-gaap	Assets Assets	6889689000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	3053884000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	3028122000	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	159659000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	198078000	USD
CY2022Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	0	USD
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	262000	USD
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	0	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	5069000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	hta	Security Deposit Liability Advance Rentand Other Liabilities SecurityDepositLiabilityAdvanceRentandOtherLiabilities	78771000	USD
CY2021Q4	hta	Security Deposit Liability Advance Rentand Other Liabilities SecurityDepositLiabilityAdvanceRentandOtherLiabilities	86225000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	196226000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	196286000	USD
CY2022Q1	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	30001000	USD
CY2021Q4	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	31331000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	3518541000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	3545373000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	229076322	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	229076322	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	228879846	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	228879846	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	2291000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2289000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5180579000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5178132000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1727000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7041000	USD
CY2022Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1971904000	USD
CY2021Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1915776000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3212693000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3257604000	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	83674000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	86712000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3296367000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3344316000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6814908000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6889689000	USD
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	200243000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	191350000	USD
CY2022Q1	us-gaap	Interest Income Operating InterestIncomeOperating	1759000	USD
CY2021Q1	us-gaap	Interest Income Operating InterestIncomeOperating	143000	USD
CY2022Q1	us-gaap	Revenues Revenues	202002000	USD
CY2021Q1	us-gaap	Revenues Revenues	191493000	USD
CY2022Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	65884000	USD
CY2021Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	59579000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12448000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10560000	USD
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6018000	USD
CY2021Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2022Q1	hta	Acquisition Related Expenses AcquisitionRelatedExpenses	144000	USD
CY2021Q1	hta	Acquisition Related Expenses AcquisitionRelatedExpenses	96000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75386000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	76274000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	23940000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	22986000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	183820000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	169495000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-4000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	400000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	392000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	88000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	18666000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	22393000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	351000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	363000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	18315000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	22030000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2021Q4	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.50
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228978000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218753000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	233046000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	222268000	shares
CY2022Q1	us-gaap	Profit Loss ProfitLoss	18666000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	22393000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	8817000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	2792000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8817000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2792000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	27483000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	25185000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	400000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	407000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	27083000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	24778000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3234919000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3337000	USD
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	3248000	USD
CY2021Q1	hta	Noncontrolling Interestand Other Redeemed During Period Value NoncontrollingInterestandOtherRedeemedDuringPeriodValue	0	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.320
CY2021Q1	us-gaap	Dividends Dividends	71206000	USD
CY2021Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	22393000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2792000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3188987000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3344316000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2024000	USD
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1640000	USD
CY2022Q1	hta	Noncontrolling Interestand Other Redeemed During Period Value NoncontrollingInterestandOtherRedeemedDuringPeriodValue	0	USD
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.325
CY2022Q1	us-gaap	Dividends Dividends	75816000	USD
CY2022Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	18666000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8817000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3296367000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	18666000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	22393000	USD
CY2022Q1	hta	Depreciation Amortizationand Other DepreciationAmortizationandOther	71009000	USD
CY2021Q1	hta	Depreciation Amortizationand Other DepreciationAmortizationandOther	71671000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2025000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3337000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	400000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	392000	USD
CY2022Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	785000	USD
CY2021Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	785000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-4000	USD
CY2022Q1	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.50
CY2021Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	3229000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	-2275000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-34131000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-27613000	USD
CY2022Q1	hta	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	-5421000	USD
CY2021Q1	hta	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	-7103000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	49308000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	65353000	USD
CY2022Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	19094000	USD
CY2021Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	30472000	USD
CY2022Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	10372000	USD
CY2021Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	17096000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	26791000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	0	USD
CY2022Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	28560000	USD
CY2021Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	28931000	USD
CY2022Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2021Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	200000	USD
CY2022Q1	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	325000	USD
CY2021Q1	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	0	USD
CY2022Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	2270000	USD
CY2021Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33180000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-76299000	USD
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	75000000	USD
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	15000000	USD
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	50000000	USD
CY2021Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	15000000	USD
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5355000	USD
CY2021Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1641000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3248000	USD
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	74377000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	70000000	USD
CY2022Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1402000	USD
CY2021Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1485000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-57775000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-74733000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-41647000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-85679000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57069000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118765000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15422000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33086000	USD
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	Organization and Description of Business <div style="margin-top:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HTA, a Maryland corporation, and HTALP, a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006. HTA operates as a REIT and is the general partner of HTALP, which is the operating partnership, in an umbrella partnership, or “UPREIT” structure. HTA has qualified and intends to continue to be taxed as a REIT for federal income tax purposes under the applicable sections of the Internal Revenue Code. </span></div><div style="margin-top:3pt;padding-right:6.75pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own real estate primarily consisting of medical office buildings (“MOBs”) located on or adjacent to hospital campuses or in off-campus, community core outpatient locations across 32 states within the United States, and we lease space to tenants primarily consisting of health systems, research and academic institutions, and various sized physician practices. Through our full-service operating platform, we provide leasing, asset management, acquisitions, development and other related services for our properties. </span></div><div style="margin-top:3pt;padding-right:6.75pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary objective is to maximize stockholder value with growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we: (i) seek internal growth through proactive asset management, leasing, building services and property management oversight; (ii) target accretive acquisitions and developments of MOBs in markets with attractive demographics that complement our existing portfolio; and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage. Additionally, from time to time we consider, on an opportunistic basis, significant portfolio acquisitions that we believe fit our core business and we expect to enhance our existing portfolio. </span></div><div style="margin-top:3pt;padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger with Healthcare Realty Trust Incorporated</span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, Healthcare Trust of America, Inc. (the “Company”), a Maryland corporation, Healthcare Trust of America Holdings, LP, a Delaware limited partnership (the “Company OP”) of which the Company is the sole general partner, HR Acquisition 2, LLC, a Maryland limited liability company and a direct, wholly owned subsidiary of the Company (“Merger Sub”), and Healthcare Realty Trust Incorporated, a Maryland corporation (“HR”), entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”). Upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into HR, with HR surviving the merger (the “Merger”). </span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, at the effective time, each outstanding share of Common Stock, $0.01 par value per share, of HR (“HR Common Stock”) will be converted into the right to receive 1.0 (the “Exchange Ratio”) share of Class A Common Stock, $0.01 par value per share, of the Company (“Company Common Stock” and, such consideration, the “Merger Consideration”). Subject to the closing of the Merger and the other transactions contemplated therein, the holders of shares of Company Common Stock issued and outstanding on the last business day prior to the closing date of the Merger will receive a special distribution in the amount of $4.82 in cash per share of Company Common Stock held on such date (the “Special Distribution Payment”).</span></div><div style="margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the conditions to close the Merger have been satisfied or waived, the Merger Agreement requires HR and the Company to exchange irrevocable certifications that all such closing conditions have been satisfied or waived. At such time, the Company OP will transfer or cause the transfer, on the business day before the effective time, to HR or its designees certain of the Company OP’s assets as specified by HR for a cash purchase price equal to the reasonably equivalent fair market value of the assets transferred. To the extent the net proceeds to the Company of the asset transfer or joint venture transactions relating to such assets are insufficient to pay the full amount of the Special Distribution Payment, the Merger Agreement requires the Company to utilize new financing to fund the balance of the Special Distribution Payment. The Company has obtained a commitment letter from JPMorgan Chase Bank, N.A. for a $1.7 billion bridge financing facility. HTA and HR have received letters of intent from, and are in advanced negotiations with, three institutional investors for a combination of joint ventures and asset sales totaling $1.7 billion at a weighted average cap rate of approximately 4.8%. Net proceeds from these transactions are expected to be approximately $1.6 billion. The transactions may occur in separate tranches, with the initial transactions targeted to close prior to the vote on the contemplated Merger by HR and HTA stockholders and the remainder to be completed on or around the closing date of the contemplated Merger. These transactions are subject to execution of definitive documentation and customary closing conditions. In addition, HTA and HR have secured initial commitments for amended and restated credit facilities, including the following: (i) a $1.5 billion revolving credit facility; (ii) $1.5 billion of term loans, including $650 million of new capacity; and (iii) a $1.1 billion asset sale term loan to replace the transaction bridge loan commitment and to backstop the $1.1 billion special dividend to HTA stockholders, if needed, depending on the timing of asset sales and joint ventures.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on May 2, 2022, HTA and HR filed a Form S-4 Registration Statement with the SEC in connection with the contemplated Merger. Please review this Form S-4 for more information about the contemplated Merger. </span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger Agreement contains customary representations, warranties and covenants by each party. The Merger is subject to certain conditions which are set forth in the Merger Agreement, including the approval of both companies’ stockholders. The boards of directors of the Company and HR have unanimously approved the Merger Agreement. The Merger is expected to close during the third quarter of 2022.</span></div><div style="margin-top:3pt;padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div>On March 11, 2020 the novel coronavirus disease (“COVID-19”) was declared a pandemic by the World Health Organization. As the virus continued to spread throughout the United States and other countries across the world, Federal, state and local governments took various actions including the issuance of “stay-at-home” orders, social distancing guidelines and ordering the temporary closure of non-essential businesses to limit the spread of COVID-19. While many businesses have reopened and vaccinations are becoming more widely available to the general population, the economic uncertainty created by the COVID-19 pandemic continue to present risks to the Company and the future results of our operations. Although we did not experience significant disruptions from the COVID-19 pandemic during the three months ended March 31, 2022, should current and planned measures, including further development and delivery of vaccines and other measures intended to reduce or eliminate the spread of COVID-19, past and/or proposed economic stimulus, and other laws, acts and orders proposed or enacted by these various governmental agencies ultimately not be successful or limited in their efficacy, our business and the broader real estate industry may experience significant adverse consequences. These consequences include loss of revenues, increased expenses, increased costs of materials, difficulty in maintaining an active workforce, and constraints on our ability to secure capital or financing, among other factors.
CY2022Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	32	state
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that effect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent asset and liabilities. These estimates are made and evaluated on an ongoing basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in adverse ways, and those estimates could be different under different assumptions or conditions.
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10944000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29990000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4478000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3096000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15422000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33086000	USD
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	72700000	USD
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	62500000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	62800000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	400000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	400000	USD
CY2022Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Including Other Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIncludingOtherNet	19100000	USD
CY2022Q1	hta	Asset Acquisition Transaction Costs Capitalized AssetAcquisitionTransactionCostsCapitalized	100000	USD
CY2022Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Land AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLand	3812000	USD
CY2021Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Land AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLand	1093000	USD
CY2022Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Buildings And Improvements AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBuildingsAndImprovements	13189000	USD
CY2021Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Buildings And Improvements AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBuildingsAndImprovements	26819000	USD
CY2022Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed In Place Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInPlaceLeases	2121000	USD
CY2021Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed In Place Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInPlaceLeases	3449000	USD
CY2022Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Below Market Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBelowMarketLeases	28000	USD
CY2021Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Below Market Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBelowMarketLeases	79000	USD
CY2022Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Above Market Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAboveMarketLeases	0	USD
CY2021Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Above Market Leases AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAboveMarketLeases	66000	USD
CY2022Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Below Market Leasehold Interests AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBelowMarketLeaseholdInterests	0	USD
CY2021Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Below Market Leasehold Interests AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBelowMarketLeaseholdInterests	876000	USD
CY2022Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNet	19094000	USD
CY2021Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNet	30472000	USD
CY2022Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Other Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherNet	0	USD
CY2021Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Other Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherNet	2397000	USD
CY2022Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Including Other Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIncludingOtherNet	19094000	USD
CY2021Q1	hta	Asset Acquisition Recognized Identifiable Assets Acquiredand Liabilities Assumed Including Other Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIncludingOtherNet	32869000	USD
CY2022Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y4M24D
CY2021Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P6Y4M24D
CY2022Q1	hta	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P4Y3M18D
CY2021Q1	hta	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P5Y8M12D
CY2022Q1	hta	Number Of Assets Disposed NumberOfAssetsDisposed	1	property
CY2021Q1	hta	Number Of Assets Disposed NumberOfAssetsDisposed	0	property
CY2021Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
CY2022Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	414580000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	426251000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	211034000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	213801000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	203546000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P9Y3M18D
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	212450000	USD
	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P9Y3M18D
CY2022Q1	hta	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	24039000	USD
CY2021Q4	hta	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	23742000	USD
CY2022Q1	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	30001000	USD
CY2022Q1	hta	Finite Lived Intangible Liabilities Weighted Average Remaining Life FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife	P14Y6M
CY2021Q4	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	31331000	USD
	hta	Finite Lived Intangible Liabilities Weighted Average Remaining Life FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife	P14Y3M18D
CY2022Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	3009000	USD
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	10477000	USD
CY2022Q1	us-gaap	Other Receivables OtherReceivables	7402000	USD
CY2021Q4	us-gaap	Other Receivables OtherReceivables	6098000	USD
CY2022Q1	hta	Deferred Financing Costs Net DeferredFinancingCostsNet	11057000	USD
CY2021Q4	hta	Deferred Financing Costs Net DeferredFinancingCostsNet	7055000	USD
CY2022Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	47612000	USD
CY2021Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	45008000	USD
CY2022Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	146378000	USD
CY2021Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	142604000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	42734000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	38301000	USD
CY2022Q1	us-gaap	Derivative Assets DerivativeAssets	3692000	USD
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	0	USD
CY2022Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	72701000	USD
CY2021Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	69114000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	16196000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	16284000	USD
CY2022Q1	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	350781000	USD
CY2021Q4	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	334941000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2227000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2223000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1353000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	431000	USD
CY2022Q1	hta	Number Of Ground Leases Commenced NumberOfGroundLeasesCommenced	1	lease
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	8028000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	473000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10846000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	635000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10370000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	640000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9857000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	645000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9860000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	656000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	9845000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	668000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	590018000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	36856000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	648824000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	40573000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	452598000	USD
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	23665000	USD
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	23665000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	196226000	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	16908000	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	16908000	USD
CY2022Q1	hta	Operating Lease Lease Incomeand Other Lease Related Income OperatingLeaseLeaseIncomeandOtherLeaseRelatedIncome	199300000	USD
CY2021Q1	hta	Operating Lease Lease Incomeand Other Lease Related Income OperatingLeaseLeaseIncomeandOtherLeaseRelatedIncome	190400000	USD
CY2022Q1	us-gaap	Variable Lease Income VariableLeaseIncome	48100000	USD
CY2021Q1	us-gaap	Variable Lease Income VariableLeaseIncome	45100000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	432329000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	537159000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	479252000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	418300000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	369927000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	301521000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	1044334000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	3582822000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3075000000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3050000000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	17199000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	17975000	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	3917000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	3903000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	3053884000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	3028122000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	200000000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	325000000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	600000000	USD
CY2022Q1	hta	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	1950000000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3075000000	USD
CY2022Q1	hta	Deferred Finance Costs Future Amortization Expense Remainder Of Fiscal Year DeferredFinanceCostsFutureAmortizationExpenseRemainderOfFiscalYear	2330000	USD
CY2022Q1	hta	Deferred Finance Costs Amortization Expense Year One DeferredFinanceCostsAmortizationExpenseYearOne	3106000	USD
CY2022Q1	hta	Deferred Finance Costs Amortization Expense Year Two DeferredFinanceCostsAmortizationExpenseYearTwo	2724000	USD
CY2022Q1	hta	Deferred Finance Costs Amortization Expense Year Three DeferredFinanceCostsAmortizationExpenseYearThree	2603000	USD
CY2022Q1	hta	Deferred Finance Costs Amortization Expense Year Four DeferredFinanceCostsAmortizationExpenseYearFour	1839000	USD
CY2022Q1	hta	Deferred Finance Costs Amortization Expense After Year Four DeferredFinanceCostsAmortizationExpenseAfterYearFour	4597000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	17199000	USD
CY2022Q1	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	1200000	USD
CY2022Q1	hta	Derivative Asset Including Interest Excluding Adjustment For Nonperformance Risk DerivativeAssetIncludingInterestExcludingAdjustmentForNonperformanceRisk	3600000	USD
CY2022Q1	hta	Equity Offering Program Availablefor Issuance EquityOfferingProgramAvailableforIssuance	750000000	USD
CY2020Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	USD
CY2022Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	300000000	USD
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	75800000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	18666000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	22393000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	351000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	363000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	18315000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	22030000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228978000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218753000	shares
CY2022Q1	hta	Incremental Common Shares Attributable To Conversion Of Partnership Units IncrementalCommonSharesAttributableToConversionOfPartnershipUnits	4068000	shares
CY2021Q1	hta	Incremental Common Shares Attributable To Conversion Of Partnership Units IncrementalCommonSharesAttributableToConversionOfPartnershipUnits	3515000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	233046000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	222268000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	39025000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	38605000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	4335000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	4554000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7620000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	19013000	USD
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	75766000	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	71146000	USD
CY2022Q1	hta	Noncash Redemption Of Noncontrolling Interests NoncashRedemptionOfNoncontrollingInterests	2065000	USD
CY2021Q1	hta	Noncash Redemption Of Noncontrolling Interests NoncashRedemptionOfNoncontrollingInterests	255000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3995000	USD

Files In Submission

Name	View Source	Status
0001360604-22-000031-index-headers.html	Edgar Link	pending
0001360604-22-000031-index.html	Edgar Link	pending
0001360604-22-000031.txt	Edgar Link	pending
0001360604-22-000031-xbrl.zip	Edgar Link	pending
a2022331ex311.htm	Edgar Link	pending
a2022331ex312.htm	Edgar Link	pending
a2022331ex313.htm	Edgar Link	pending
a2022331ex314.htm	Edgar Link	pending
a2022331ex321.htm	Edgar Link	pending
a2022331ex322.htm	Edgar Link	pending
a2022331ex323.htm	Edgar Link	pending
a2022331ex324.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hta-20220331.htm	Edgar Link	pending
hta-20220331.xsd	Edgar Link	pending
hta-20220331_cal.xml	Edgar Link	unprocessable
hta-20220331_def.xml	Edgar Link	unprocessable
hta-20220331_htm.xml	Edgar Link	completed
hta-20220331_lab.xml	Edgar Link	unprocessable
hta-20220331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HR
Healthcare Realty Trust Inc Stock $hr

2022 Q1 Form 10-Q Financial Statement

#000136060422000031 Filed on May 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HR Healthcare Realty Trust Inc Stock $hr

2022 Q1 Form 10-Q Financial Statement

#000136060422000031 Filed on May 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HR
Healthcare Realty Trust Inc Stock $hr